How do patterns of progression influence treatment selection after chemohormonal therapy in patients with metastatic hormone sensitive prostate cancer?

被引：1
|
作者：
De La Rosa, Carlos Aguado
Carbonero, Iciar Garcia
De Velasco, Guillermo
Alonso, Teresa
Villalobos, Maria L.
Garrido, Maria
Gallegos, Isabel
Martin, Almudena
Pinto, Alvaro
Alonso, Constanza Maximiano
Rodriguez-Moreno, J. F.
Rodriguez, Laura
Sereno, Maria
Perezagua, Carmen
Marrupe, David
Riquelme, Alejandro
Cassinello, Javier
Grande, Enrique
Puente, Javier
Gajate, Pablo
机构：
[1] Hosp Univ Clin San Carlos, Madrid, Spain
[2] Hosp Virgen Salud, Toledo, Spain
[3] Hosp Univ 12 Octubre, Madrid, Spain
[4] Hosp Univ Ramon y Cajal, Madrid, Spain
[5] Hosp Univ Principe Asturias, Madrid, Spain
[6] Hosp Univ Severo Ochoa, Madrid, Spain
[7] Hosp Gen Segovia, Segovia, Spain
[8] Hosp Infanta Leonor, Madrid, Spain
[9] Hosp Univ La Paz, Madrid, Spain
[10] Hosp Univ Puerta Hierro, Madrid, Spain
[11] Ctr Integral Oncol Clara Campal, Madrid, Spain
[12] Hosp Univ Fuenlabrada, Fuenlabrada, Spain
[13] Hosp Univ Infanta Sofia, Madrid, Spain
[14] Hosp Univ Henares, Coslada, Spain
[15] Hosp Univ Mostoles, Mostoles, Spain
[16] Hosp Univ Infanta Cristina, Parla, Spain
[17] Hosp Univ Guadalajara, Guadalajara, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e16504
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16504
引用
收藏
页数：5
相关论文
共 50 条
  • [41] The role of chemotherapy in the treatment of hormone sensitive metastatic prostate cancer
    Luis Perez-Gracia, Jose
    Diez Caballero, Fernando
    Gurpide, Alfonso
    de Fata Chillon, Fernando Ramon
    Villacampa, Felipe
    ARCHIVOS ESPANOLES DE UROLOGIA, 2018, 71 (03): : 276 - 280
  • [42] Advancements in the treatment of metastatic hormone-sensitive prostate cancer
    Li, Hengping
    Zhang, Mao
    Wang, Xiangrong
    Liu, Yang
    Li, Xuanpeng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [43] Metastatic hormone sensitive prostate cancer: local treatment strategies
    Jochen Walz
    Geraldine Pignot
    Sami Fakhfakh
    Jennifer Campagna
    Mathilde Guerin
    Cecile Vicier
    Serge Brunelle
    Naji Salem
    Gwenaelle Gravis
    World Journal of Urology, 2021, 39 : 327 - 337
  • [44] Optimal treatment for metastatic hormone-sensitive prostate cancer
    Omlin, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 18 - 19
  • [45] Treatment options for metastatic hormone-sensitive prostate cancer
    Kostos, Louise
    Murphy, Declan G.
    LANCET ONCOLOGY, 2022, 23 (10): : 1234 - 1235
  • [46] Modern treatment of metastatic hormone-sensitive prostate cancer
    Kuronya Zsofia
    Biro Krisztina
    Geczi Lajos
    Maraz Aniko
    ORVOSI HETILAP, 2018, 159 (41) : 1664 - 1671
  • [47] Metastatic hormone-sensitive prostate cancer: How should it be treated?
    Lopez-Campos, Fernando
    Gonzalez-San Segundo, Carmen
    Conde-Moreno, Antonio Jose
    Counago, Felipe
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (02): : 43 - 49
  • [48] How I Treat Metastatic Hormone-Sensitive Prostate Cancer?
    Dabkara, Deepak
    Mondal, Debapriya
    Ghosh, Joydeep
    Biswas, Bivas
    Ganguly, Sandip
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (01) : 100 - 107
  • [49] Androgen deprivation therapy ± new antihormonal therapy for the treatment of metastatic hormone-sensitive prostate cancer
    Boegemann, Martin
    UROLOGIE, 2023, 62 (04): : 354 - 359
  • [50] Low TLR and PSMA-TV predict biochemical response to abiraterone acetate in metastatic prostate cancer patients developing castration resistance after chemohormonal therapy at hormone-sensitive stage
    Zhi-Bin Ke
    Jia-Yin Chen
    Qi You
    Jiang-Bo Sun
    Yu-Ting Xue
    Xiao-Jian Ye
    Shao-Hao Chen
    Xue-Yi Xue
    Xiong-Lin Sun
    Dong-Ning Chen
    Yong Wei
    Qing-Shui Zheng
    Shao-Ming Chen
    Ning Xu
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 5071 - 5084
12345